These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 15659005

  • 1. Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia.
    Ren XS, Huang YH, Lee AF, Miller DR, Qian S, Kazis L.
    J Clin Pharm Ther; 2005 Feb; 30(1):65-71. PubMed ID: 15659005
    [Abstract] [Full Text] [Related]

  • 2. Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia.
    Ren XS, Lee AF, Huang YH, Hamed A, Herz L, Miller DR, Kazis LE.
    J Clin Pharm Ther; 2004 Oct; 29(5):471-81. PubMed ID: 15482392
    [Abstract] [Full Text] [Related]

  • 3. Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia.
    Ren XS, Kazis LE, Lee AF, Huang YH, Hamed A, Cunningham F, Herz L, Miller DR.
    Schizophr Res; 2005 Sep 15; 77(2-3):167-77. PubMed ID: 15894460
    [Abstract] [Full Text] [Related]

  • 4. Selective prescribing of atypical antipsychotics.
    Breekveldt-Postma NS, Schillevoort I, Nolen WA, Veraart CP, Herings RM.
    Pharmacoepidemiol Drug Saf; 2005 Jan 15; 14(1):25-30. PubMed ID: 15508132
    [Abstract] [Full Text] [Related]

  • 5. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S, Agoston T, Tamás T, Zoltán J.
    Neuropsychopharmacol Hung; 2007 Oct 15; 9(3):115-24. PubMed ID: 18399029
    [Abstract] [Full Text] [Related]

  • 6. Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents.
    Ren XS, Qian S, Lee AF, Herz L, Miller DR, Kazis LE.
    J Clin Pharm Ther; 2006 Feb 15; 31(1):57-65. PubMed ID: 16476121
    [Abstract] [Full Text] [Related]

  • 7. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
    Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, Lapointe JS, Honer WG.
    Am J Psychiatry; 2004 Oct 15; 161(10):1829-36. PubMed ID: 15465980
    [Abstract] [Full Text] [Related]

  • 8. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
    Ascher-Svanum H, Zhu B, Faries D, Landbloom R, Swartz M, Swanson J.
    BMC Psychiatry; 2006 Feb 21; 6():8. PubMed ID: 16504026
    [Abstract] [Full Text] [Related]

  • 9. Comparison of treatment-emergent extrapyramidal symptoms in patients with bipolar mania or schizophrenia during olanzapine clinical trials.
    Cavazzoni PA, Berg PH, Kryzhanovskaya LA, Briggs SD, Roddy TE, Tohen M, Kane JM.
    J Clin Psychiatry; 2006 Jan 21; 67(1):107-13. PubMed ID: 16426096
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M, Erol A, el Mahfoud Kessaci M, Shaheen MO, Sunbol MM, Boland J, Hodge A, O'Halloran RA, Bitter I, IC-SOHO Study Group.
    J Clin Psychiatry; 2004 Mar 21; 65(3):312-21. PubMed ID: 15096069
    [Abstract] [Full Text] [Related]

  • 11. Safety and tolerability of olanzapine compared with other antipsychotics in the treatment of elderly patients with schizophrenia: a naturalistic study.
    Ciudad A, Montes JM, Olivares JM, Gómez JC, EFESO Study Group.
    Eur Psychiatry; 2004 Sep 21; 19(6):358-65. PubMed ID: 15363475
    [Abstract] [Full Text] [Related]

  • 12. International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia.
    Jeste DV, Barak Y, Madhusoodanan S, Grossman F, Gharabawi G.
    Am J Geriatr Psychiatry; 2003 Sep 21; 11(6):638-47. PubMed ID: 14609804
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia.
    Lee C, Wu KH, Habil H, Dyachkova Y, Lee P.
    Aust N Z J Psychiatry; 2006 May 21; 40(5):437-45. PubMed ID: 16683970
    [Abstract] [Full Text] [Related]

  • 17. Anticholinergic use in children and adolescents after initiation of antipsychotic therapy.
    Hong IS, Bishop JR.
    Ann Pharmacother; 2010 May 21; 44(7-8):1171-80. PubMed ID: 20587746
    [Abstract] [Full Text] [Related]

  • 18. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J, Postma MJ, Bruggeman R, De Jong-Van Den Berg LT, Van Den Berg PB, Stolk RP, Burger H.
    J Clin Psychopharmacol; 2008 Dec 21; 28(6):625-30. PubMed ID: 19011430
    [Abstract] [Full Text] [Related]

  • 19. A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.
    Chan HY, Chang CJ, Chiang SC, Chen JJ, Chen CH, Sun HJ, Hwu HG, Lai MS.
    J Psychopharmacol; 2010 Jan 21; 24(1):91-8. PubMed ID: 18801830
    [Abstract] [Full Text] [Related]

  • 20. A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: the QUERISOLA trial.
    Sacchetti E, Valsecchi P, Parrinello G, QUERISOLA Group.
    Schizophr Res; 2008 Jan 21; 98(1-3):55-65. PubMed ID: 17933497
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.